PMID: 15371903

Sugarman EA, Rohlfs EM, Silverman LM, Allitto BA
CFTR mutation distribution among U.S. Hispanic and African American individuals: evaluation in cystic fibrosis patient and carrier screening populations.
Genet Med. 2004 Sep-Oct;6(5):392-9., [PubMed]
Sentences
No. Mutations Sentence Comment
4 ABCC7 p.Ser549Asn
X
ABCC7 p.Ser549Asn 15371903:4:96
status: NEW
view ABCC7 p.Ser549Asn details
ABCC7 p.Arg1066Cys
X
ABCC7 p.Arg1066Cys 15371903:4:88
status: NEW
view ABCC7 p.Arg1066Cys details
ABCC7 p.Trp1089*
X
ABCC7 p.Trp1089* 15371903:4:80
status: NEW
view ABCC7 p.Trp1089* details
Five mutations not included in the ACMG/ACOG carrier screening panel (3876delA, W1089X, R1066C, S549N, 1949del84) accounted for 7.55% detection in patients and 5.58% among carriers. Login to comment
6 ABCC7 p.Ala559Thr
X
ABCC7 p.Ala559Thr 15371903:6:10
status: NEW
view ABCC7 p.Ala559Thr details
Together, A559T and 711ϩ5GϾA were observed at a detection rate of 3.71% in CF patients and 6.38% in carriers. Login to comment
7 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 15371903:7:160
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Leu206Trp
X
ABCC7 p.Leu206Trp 15371903:7:171
status: NEW
view ABCC7 p.Leu206Trp details
ABCC7 p.Asp1152His
X
ABCC7 p.Asp1152His 15371903:7:152
status: NEW
view ABCC7 p.Asp1152His details
The mutation distribution seen in both the carrier screening populations reflected an increased frequency of mutations with variable expression such as D1152H, R117H, and L206W. Login to comment
33 ABCC7 p.Asp1270Asn
X
ABCC7 p.Asp1270Asn 15371903:33:23
status: NEW
view ABCC7 p.Asp1270Asn details
ABCC7 p.Ile148Thr
X
ABCC7 p.Ile148Thr 15371903:33:45
status: NEW
view ABCC7 p.Ile148Thr details
Specimens positive for D1270N (see later) or I148T in the absence of 3199del6 were reclassified as negative for the purpose of this analysis. Login to comment
34 ABCC7 p.Ile148Thr
X
ABCC7 p.Ile148Thr 15371903:34:24
status: NEW
view ABCC7 p.Ile148Thr details
Specimens identified as I148T positive before the start of 3199del6 reflex testing are included in the analysis because their disease causing status is unknown. Login to comment
35 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 15371903:35:183
status: NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 15371903:35:319
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Pro574His
X
ABCC7 p.Pro574His 15371903:35:239
status: NEW
view ABCC7 p.Pro574His details
ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 15371903:35:112
status: NEW
view ABCC7 p.Ala455Glu details
ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 15371903:35:450
status: NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Arg553*
X
ABCC7 p.Arg553* 15371903:35:362
status: NEW
view ABCC7 p.Arg553* details
ABCC7 p.Arg334Trp
X
ABCC7 p.Arg334Trp 15371903:35:334
status: NEW
view ABCC7 p.Arg334Trp details
ABCC7 p.Arg347Pro
X
ABCC7 p.Arg347Pro 15371903:35:348
status: NEW
view ABCC7 p.Arg347Pro details
ABCC7 p.Arg347His
X
ABCC7 p.Arg347His 15371903:35:341
status: NEW
view ABCC7 p.Arg347His details
ABCC7 p.Asn1303Lys
X
ABCC7 p.Asn1303Lys 15371903:35:231
status: NEW
view ABCC7 p.Asn1303Lys details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 15371903:35:176
status: NEW
view ABCC7 p.Gly542* details
ABCC7 p.Arg1162*
X
ABCC7 p.Arg1162* 15371903:35:304
status: NEW
view ABCC7 p.Arg1162* details
ABCC7 p.Asp1270Asn
X
ABCC7 p.Asp1270Asn 15371903:35:141
status: NEW
view ABCC7 p.Asp1270Asn details
ABCC7 p.Ser1251Asn
X
ABCC7 p.Ser1251Asn 15371903:35:384
status: NEW
view ABCC7 p.Ser1251Asn details
ABCC7 p.Arg352Gln
X
ABCC7 p.Arg352Gln 15371903:35:355
status: NEW
view ABCC7 p.Arg352Gln details
ABCC7 p.Ile148Thr
X
ABCC7 p.Ile148Thr 15371903:35:202
status: NEW
view ABCC7 p.Ile148Thr details
ABCC7 p.Leu206Trp
X
ABCC7 p.Leu206Trp 15371903:35:216
status: NEW
view ABCC7 p.Leu206Trp details
ABCC7 p.Gln493*
X
ABCC7 p.Gln493* 15371903:35:267
status: NEW
view ABCC7 p.Gln493* details
ABCC7 p.Val520Phe
X
ABCC7 p.Val520Phe 15371903:35:435
status: NEW
view ABCC7 p.Val520Phe details
ABCC7 p.Ser549Arg
X
ABCC7 p.Ser549Arg 15371903:35:421
status: NEW
view ABCC7 p.Ser549Arg details
ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 15371903:35:190
status: NEW
view ABCC7 p.Gly85Glu details
ABCC7 p.Ser549Asn
X
ABCC7 p.Ser549Asn 15371903:35:414
status: NEW
view ABCC7 p.Ser549Asn details
ABCC7 p.Arg560Thr
X
ABCC7 p.Arg560Thr 15371903:35:369
status: NEW
view ABCC7 p.Arg560Thr details
ABCC7 p.Thr338Ile
X
ABCC7 p.Thr338Ile 15371903:35:428
status: NEW
view ABCC7 p.Thr338Ile details
ABCC7 p.Arg1158*
X
ABCC7 p.Arg1158* 15371903:35:296
status: NEW
view ABCC7 p.Arg1158* details
ABCC7 p.Ser549Ile
X
ABCC7 p.Ser549Ile 15371903:35:407
status: NEW
view ABCC7 p.Ser549Ile details
ABCC7 p.Met1101Lys
X
ABCC7 p.Met1101Lys 15371903:35:223
status: NEW
view ABCC7 p.Met1101Lys details
ABCC7 p.Arg1066Cys
X
ABCC7 p.Arg1066Cys 15371903:35:288
status: NEW
view ABCC7 p.Arg1066Cys details
ABCC7 p.Tyr1092*
X
ABCC7 p.Tyr1092* 15371903:35:458
status: NEW
view ABCC7 p.Tyr1092* details
ABCC7 p.Ser1255*
X
ABCC7 p.Ser1255* 15371903:35:392
status: NEW
view ABCC7 p.Ser1255* details
ABCC7 p.Gln552*
X
ABCC7 p.Gln552* 15371903:35:274
status: NEW
view ABCC7 p.Gln552* details
ABCC7 p.Asp1152His
X
ABCC7 p.Asp1152His 15371903:35:133
status: NEW
view ABCC7 p.Asp1152His details
ABCC7 p.Arg1283Met
X
ABCC7 p.Arg1283Met 15371903:35:326
status: NEW
view ABCC7 p.Arg1283Met details
ABCC7 p.Lys710*
X
ABCC7 p.Lys710* 15371903:35:209
status: NEW
view ABCC7 p.Lys710* details
ABCC7 p.Arg117Cys
X
ABCC7 p.Arg117Cys 15371903:35:312
status: NEW
view ABCC7 p.Arg117Cys details
ABCC7 p.Gly91Arg
X
ABCC7 p.Gly91Arg 15371903:35:196
status: NEW
view ABCC7 p.Gly91Arg details
ABCC7 p.Gln890*
X
ABCC7 p.Gln890* 15371903:35:281
status: NEW
view ABCC7 p.Gln890* details
ABCC7 p.Trp1089*
X
ABCC7 p.Trp1089* 15371903:35:442
status: NEW
view ABCC7 p.Trp1089* details
ABCC7 p.Gly480Cys
X
ABCC7 p.Gly480Cys 15371903:35:169
status: NEW
view ABCC7 p.Gly480Cys details
ABCC7 p.Ser1196*
X
ABCC7 p.Ser1196* 15371903:35:376
status: NEW
view ABCC7 p.Ser1196* details
ABCC7 p.Glu60*
X
ABCC7 p.Glu60* 15371903:35:149
status: NEW
view ABCC7 p.Glu60* details
ABCC7 p.Gly178Arg
X
ABCC7 p.Gly178Arg 15371903:35:155
status: NEW
view ABCC7 p.Gly178Arg details
ABCC7 p.Thr360Lys
X
ABCC7 p.Thr360Lys 15371903:35:260
status: NEW
view ABCC7 p.Thr360Lys details
ABCC7 p.Tyr563Asp
X
ABCC7 p.Tyr563Asp 15371903:35:466
status: NEW
view ABCC7 p.Tyr563Asp details
ABCC7 p.Gln1238*
X
ABCC7 p.Gln1238* 15371903:35:246
status: NEW
view ABCC7 p.Gln1238* details
ABCC7 p.Cys524*
X
ABCC7 p.Cys524* 15371903:35:126
status: NEW
view ABCC7 p.Cys524* details
ABCC7 p.Gln359Lys
X
ABCC7 p.Gln359Lys 15371903:35:254
status: NEW
view ABCC7 p.Gln359Lys details
ABCC7 p.Ser364Pro
X
ABCC7 p.Ser364Pro 15371903:35:400
status: NEW
view ABCC7 p.Ser364Pro details
ABCC7 p.Gly330*
X
ABCC7 p.Gly330* 15371903:35:162
status: NEW
view ABCC7 p.Gly330* details
ABCC7 p.Ala559Thr
X
ABCC7 p.Ala559Thr 15371903:35:119
status: NEW
view ABCC7 p.Ala559Thr details
87 mutation panel The following mutations were included in the panel: ⌬F508, ⌬F311, ⌬I507, A455E, A559T, C524X, D1152H, D1270N, E60X, G178R, G330X, G480C, G542X, G551D, G85E, G91R, I148T, K710X, L206W, M1101K, N1303K, P574H, Q1238X, Q359K/T360K, Q493X, Q552X, Q890X, R1066C, R1158X, R1162X, R117C, R117H, R1283M, R334W, R347H, R347P, R352Q, R553X, R560T, S1196X, S1251N, S1255X, S364P, S549I, S549N, S549R, T338I, V520F, W1089X, W1282X, Y1092X, Y563D, 1078delT, 1161delC, 1609delCA, 1677delTA, 1717-1GϾA, 1812-1GϾA, 1898ϩ1GϾA, 1898ϩ5GϾT, 1949del84, 2043delG, 2143delT, 2183delAAϾG, 2184delA, 2307insA, 2789ϩ5GϾA, 2869insG, 3120ϩ1GϾA, 3120GϾA, 3659delC, 3662delA, 3791delC, 3821delT, 3849ϩ10kbCϾT, 3849ϩ4AϾG, 3905insT, 394delTT, 405ϩ1GϾA, 405ϩ3AϾC, 444delA, 574delA, 621ϩ1GϾT, 711ϩ1GϾT, 711ϩ5GϾA, 712-1GϾT, 3876delA CFTR mutation analysis Genomic DNA was extracted from peripheral blood lymphocytes, buccal cell swabs, or bloodspots by Qiagen QIAmp 96 DNA Blood Kit. Specimens were tested for 87 mutations by a pooled allele-specific oligonucleotide (ASO) hybridization method as previously described.16,17 Two multiplex chain reactions (PCR) were used to amplify 19 regions of the CFTR gene. Login to comment
43 ABCC7 p.Asp1270Asn
X
ABCC7 p.Asp1270Asn 15371903:43:0
status: NEW
view ABCC7 p.Asp1270Asn details
ABCC7 p.Asp1270Asn
X
ABCC7 p.Asp1270Asn 15371903:43:37
status: NEW
view ABCC7 p.Asp1270Asn details
ABCC7 p.Arg74Trp
X
ABCC7 p.Arg74Trp 15371903:43:7
status: NEW
view ABCC7 p.Arg74Trp details
ABCC7 p.Arg74Trp
X
ABCC7 p.Arg74Trp 15371903:43:185
status: NEW
view ABCC7 p.Arg74Trp details
D1270N/R74W analysis A subset of 192 D1270N-positive samples derived from this sample set as well as samples received for a variety of indications and ethnicities were analyzed for the R74W sequence change using LightCycler (Roche) amplification and melting curve analysis. Login to comment
56 ABCC7 p.Arg334Trp
X
ABCC7 p.Arg334Trp 15371903:56:89
status: NEW
view ABCC7 p.Arg334Trp details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 15371903:56:82
status: NEW
view ABCC7 p.Gly542* details
ABCC7 p.Arg1066Cys
X
ABCC7 p.Arg1066Cys 15371903:56:141
status: NEW
view ABCC7 p.Arg1066Cys details
ABCC7 p.Trp1089*
X
ABCC7 p.Trp1089* 15371903:56:119
status: NEW
view ABCC7 p.Trp1089* details
Among 318 CF patient chromosomes, 30 mutations were identified with ⌬F508, G542X, R334W, 3120ϩ1GϾA, W1089X, 3876delA, and R1066C representing 52.52% of the total. Login to comment
63 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 15371903:63:68
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg553*
X
ABCC7 p.Arg553* 15371903:63:144
status: NEW
view ABCC7 p.Arg553* details
ABCC7 p.Arg334Trp
X
ABCC7 p.Arg334Trp 15371903:63:181
status: NEW
view ABCC7 p.Arg334Trp details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 15371903:63:75
status: NEW
view ABCC7 p.Gly542* details
ABCC7 p.Ile148Thr
X
ABCC7 p.Ile148Thr 15371903:63:89
status: NEW
view ABCC7 p.Ile148Thr details
ABCC7 p.Leu206Trp
X
ABCC7 p.Leu206Trp 15371903:63:82
status: NEW
view ABCC7 p.Leu206Trp details
ABCC7 p.Arg1066Cys
X
ABCC7 p.Arg1066Cys 15371903:63:136
status: NEW
view ABCC7 p.Arg1066Cys details
ABCC7 p.Asp1152His
X
ABCC7 p.Asp1152His 15371903:63:60
status: NEW
view ABCC7 p.Asp1152His details
The most prevalent mutations were as follows: ⌬F508, D1152H, R117H, G542X, L206W, I148T (3199del6 status unknown), ⌬I507, R1066C, R553X, 3849ϩ10kbCϾT, and R334W representing 83.72% of the total identified. Login to comment
69 ABCC7 p.Arg334Trp
X
ABCC7 p.Arg334Trp 15371903:69:99
status: NEW
view ABCC7 p.Arg334Trp details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 15371903:69:92
status: NEW
view ABCC7 p.Gly542* details
ABCC7 p.Arg1066Cys
X
ABCC7 p.Arg1066Cys 15371903:69:151
status: NEW
view ABCC7 p.Arg1066Cys details
ABCC7 p.Trp1089*
X
ABCC7 p.Trp1089* 15371903:69:22
status: NEW
view ABCC7 p.Trp1089* details
ABCC7 p.Trp1089*
X
ABCC7 p.Trp1089* 15371903:69:139
status: NEW
view ABCC7 p.Trp1089* details
With the exception of W1089X, the next 6 most frequent mutations in the patient population (G542X, R334W, 3120ϩ1GϾA, 3876delA, W1089X, and R1066C) were all seen in the carrier population at frequencies of 1.4% to 4.2%. Login to comment
70 ABCC7 p.Trp1089*
X
ABCC7 p.Trp1089* 15371903:70:4
status: NEW
view ABCC7 p.Trp1089* details
The W1089X mutation, which accounted for 2.2% detection among CF patients, was not seen in the carrier population. Login to comment
71 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 15371903:71:53
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Ile148Thr
X
ABCC7 p.Ile148Thr 15371903:71:995
status: NEW
view ABCC7 p.Ile148Thr details
ABCC7 p.Ile148Thr
X
ABCC7 p.Ile148Thr 15371903:71:1147
status: NEW
view ABCC7 p.Ile148Thr details
ABCC7 p.Leu206Trp
X
ABCC7 p.Leu206Trp 15371903:71:78
status: NEW
view ABCC7 p.Leu206Trp details
ABCC7 p.Asp1152His
X
ABCC7 p.Asp1152His 15371903:71:45
status: NEW
view ABCC7 p.Asp1152His details
In the carrier screening group, 4 mutations, D1152H, R117H, ⌬I507, and L206W, had frequencies of 3.8% 1 CFTR mutation distribution among Hispanic CF patients and carrier screening referrals CFTR Mutation Identified CF Patients Carrier Screening Referrals # of CF Chromosomes % Detection # of Carrier Screen Referrals % of Positive Carriers ⌬F508a 118 37.11c 136 47.39 G542Xa 11 3.46 12 4.18 R334Wa 11 3.46 6 2.09 3120 ϩ 1G Ͼ Aa 7 2.20 5 1.74 3876delAb 7 2.20 4 1.39 W1089Xb 7 2.20 R1066Cb 6 1.89 9 3.14 3849 ϩ 10kbC Ͼ Ta 3 0.94 6 2.09 R1162Xa 2 0.63 5 1.74 G85Ea 2 0.63 3 1.05 S549Nb 2 0.63 2 0.70 711 ϩ 1G Ͼ Ta 2 0.63 1 0.35 2789 ϩ 5G Ͼ Aa 2 0.63 1 0.35 1949del84b 2 0.63 1 0.35 R117Ha 1 0.31 14 4.88 ⌬I507a 1 0.31 11 3.83 R553Xa 1 0.31 7 2.44 ⌬F311b 1 0.31 1 0.35 1078delTa 1 0.31 1 0.35 621 ϩ 1G Ͼ Ta 1 0.31 1 0.35 3659delCa 1 0.31 1 0.35 Q890Xb 1 0.31 1 0.35 G551Da 1 0.31 1812 - 1G Ͼ Ab 1 0.31 I148T ϩ 3199del6a 1 0.31 A559Tb 1 0.31 1717 - 1G Ͼ Aa 1 0.31 3905insTb 1 0.31 3821delTb 1 0.31 G178Rb 1 0.31 D1152Hb 18 6.27 L206Wb 11 3.83 I148T (3199del6 status unknown)a 10 3.48 N1303Ka 4 1.39 W1282Xa 4 1.39 R117Cb 4 1.39 R352Qb 2 0.70 712 - 1G Ͼ Tb 2 0.70 Y1092Xb 1 0.35 444delAb 1 0.35 S549Rb 1 0.35 1609delCAb 1 0.35 Negative for mutations analyzed 120 37.74 15046 Total 318 62.20d 15333 100.00 a Mutation included in the ACMG/ACOG Recommended Core Mutation Panel for general population CF carrier screening.4,5 b Mutation not included in the ACMG/ACOG Recommended Core Mutation Panel for general population CF carrier screening. Login to comment
76 ABCC7 p.Ala559Thr
X
ABCC7 p.Ala559Thr 15371903:76:80
status: NEW
view ABCC7 p.Ala559Thr details
The most frequent mutations (⌬F508, 3120ϩ1GϾA, 2307insA, and A559T) have been previously reported to be frequent in the African American population19 and represent 46.77% of the total. Login to comment
84 ABCC7 p.Arg553*
X
ABCC7 p.Arg553* 15371903:84:125
status: NEW
view ABCC7 p.Arg553* details
ABCC7 p.Ala559Thr
X
ABCC7 p.Ala559Thr 15371903:84:106
status: NEW
view ABCC7 p.Ala559Thr details
After ⌬F508, the next most-frequent mutations were 3120ϩ1GϾA (8.8%), 2307insA (4.17%), A559T (2.78%), and R553X (1.39%). Login to comment
86 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 15371903:86:27
status: NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 15371903:86:51
status: NEW
view ABCC7 p.Gly542* details
An additional 4 mutations (G551D, 1717-1GϾA, G542X, 711ϩ5GϾA) were detected twice (0.93% each), whereas 12 other mutations were identified on one chromosome each. Login to comment
87 ABCC7 p.Ser1255*
X
ABCC7 p.Ser1255* 15371903:87:133
status: NEW
view ABCC7 p.Ser1255* details
ABCC7 p.Gly480Cys
X
ABCC7 p.Gly480Cys 15371903:87:113
status: NEW
view ABCC7 p.Gly480Cys details
ABCC7 p.Gly330*
X
ABCC7 p.Gly330* 15371903:87:106
status: NEW
view ABCC7 p.Gly330* details
Five of the twelve mutations identified once are considered to be "African American" mutations (3791delC, G330X, G480C, 444delA, and S1255X).19 African American CF carrier screening population Among the 8,973 African American individuals referred for carrier screening, 23 different mutations were identified among 94 (1/95) carriers (Table 2). Login to comment
88 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 15371903:88:104
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Ala559Thr
X
ABCC7 p.Ala559Thr 15371903:88:85
status: NEW
view ABCC7 p.Ala559Thr details
The most frequent mutations were ⌬F508 (52.1%), 3120ϩ1GϾA (9.6%), A559T (6.38%), and R117H (5.32%). Login to comment
91 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 15371903:91:91
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Asp1152His
X
ABCC7 p.Asp1152His 15371903:91:103
status: NEW
view ABCC7 p.Asp1152His details
These include mutations known to be associated with variable phenotypic expression such as R117H,21,22 D1152H,23-25 and 3849ϩ10kbCϾT.27,28 Assuming Ϸ74% detection for the mutations analyzed and an observed carrier frequency of 1/95, an adjustment to 100% detection would result in a carrier frequency of 1/76, which is not significantly different than the expected 1/613 based on the disease incidence (P ϭ 0.1779). Login to comment
92 ABCC7 p.Asp1270Asn
X
ABCC7 p.Asp1270Asn 15371903:92:47
status: NEW
view ABCC7 p.Asp1270Asn details
ABCC7 p.Asp1270Asn
X
ABCC7 p.Asp1270Asn 15371903:92:113
status: NEW
view ABCC7 p.Asp1270Asn details
Reclassification of specimens positive for the D1270N sequence change Mutation analysis for all samples included D1270N. Login to comment
93 ABCC7 p.Asp1270Asn
X
ABCC7 p.Asp1270Asn 15371903:93:14
status: NEW
view ABCC7 p.Asp1270Asn details
Comparison of D1270N chromosomes between African American CF patients and carrier screening referrals revealed a Ͼ 100-fold increase among carriers (2 CF patient chromosomes: 228 CF carrier alleles). Login to comment
94 ABCC7 p.Asp1270Asn
X
ABCC7 p.Asp1270Asn 15371903:94:59
status: NEW
view ABCC7 p.Asp1270Asn details
ABCC7 p.Asp1270Asn
X
ABCC7 p.Asp1270Asn 15371903:94:93
status: NEW
view ABCC7 p.Asp1270Asn details
ABCC7 p.Arg74Trp
X
ABCC7 p.Arg74Trp 15371903:94:47
status: NEW
view ABCC7 p.Arg74Trp details
ABCC7 p.Arg74Trp
X
ABCC7 p.Arg74Trp 15371903:94:141
status: NEW
view ABCC7 p.Arg74Trp details
To investigate a potential modifying effect of R74W on the D1270N phenotype, we analyzed 192 D1270N-positive individuals for the presence of R74W.29 Patients were of varying ethnicities (46.4% African American, 29.2% Hispanic, 11.9% Caucasian, 12.5% Other/Mix/Not Provided) and indications (Table 4). Login to comment
95 ABCC7 p.Asp1270Asn
X
ABCC7 p.Asp1270Asn 15371903:95:80
status: NEW
view ABCC7 p.Asp1270Asn details
ABCC7 p.Arg74Trp
X
ABCC7 p.Arg74Trp 15371903:95:91
status: NEW
view ABCC7 p.Arg74Trp details
Two individuals with the indication of carrier testing were homozygous for both D1270N and R74W. Login to comment
97 ABCC7 p.Asp1270Asn
X
ABCC7 p.Asp1270Asn 15371903:97:95
status: NEW
view ABCC7 p.Asp1270Asn details
ABCC7 p.Arg74Trp
X
ABCC7 p.Arg74Trp 15371903:97:118
status: NEW
view ABCC7 p.Arg74Trp details
Six individuals carried the genotype of a severe CF mutation (i.e., ⌬F508), one copy of D1270N and one copy of R74W. Login to comment
99 ABCC7 p.Asp1270Asn
X
ABCC7 p.Asp1270Asn 15371903:99:70
status: NEW
view ABCC7 p.Asp1270Asn details
ABCC7 p.Arg74Trp
X
ABCC7 p.Arg74Trp 15371903:99:93
status: NEW
view ABCC7 p.Arg74Trp details
Among those samples (n ϭ 167) received for carrier testing, 169 D1270N alleles and 159 R74W alleles were detected. Login to comment
100 ABCC7 p.Asp1270Asn
X
ABCC7 p.Asp1270Asn 15371903:100:75
status: NEW
view ABCC7 p.Asp1270Asn details
ABCC7 p.Arg74Trp
X
ABCC7 p.Arg74Trp 15371903:100:105
status: NEW
view ABCC7 p.Arg74Trp details
While we were unable to determine phase, overall 94% of individuals with a D1270N allele also carried an R74W allele. Login to comment
101 ABCC7 p.Asp1270Asn
X
ABCC7 p.Asp1270Asn 15371903:101:58
status: NEW
view ABCC7 p.Asp1270Asn details
ABCC7 p.Arg74Trp
X
ABCC7 p.Arg74Trp 15371903:101:66
status: NEW
view ABCC7 p.Arg74Trp details
In this data set there is no apparent correlation between D1270N, R74W, and phenotype. Login to comment
102 ABCC7 p.Asp1270Asn
X
ABCC7 p.Asp1270Asn 15371903:102:4
status: NEW
view ABCC7 p.Asp1270Asn details
The D1270N sequence change was therefore not included in analysis of data for the larger study and has subsequently been removed from our CF test. Login to comment
108 ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 15371903:108:349
status: NEW
view ABCC7 p.Gly542* details
ABCC7 p.Trp1089*
X
ABCC7 p.Trp1089* 15371903:108:230
status: NEW
view ABCC7 p.Trp1089* details
In the current study, 42 different mutations were identified among the Hispanic individuals (patients and carriers) tested and the most common mutations included those previously reported to be common among Hispanics, 3876delA,32 W1089X,17 as well as mutations considered frequent in African Americans (3120ϩ1GϾA)19 and panethnic (e.g., G542X, ⌬I507) populations.33 Although regional variation in overall detection rates may occur, these data provide general guidance when developing a panethnic mutation panel and information useful for genetic counseling purposes. Login to comment
112 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 15371903:112:119
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Leu206Trp
X
ABCC7 p.Leu206Trp 15371903:112:138
status: NEW
view ABCC7 p.Leu206Trp details
ABCC7 p.Asp1152His
X
ABCC7 p.Asp1152His 15371903:112:126
status: NEW
view ABCC7 p.Asp1152His details
In both the Hispanic and African American populations, mutations associated with a variable clinical phenotype such as R117H, D1152H, and L206W were more common in the carrier screening population than the affected population. Login to comment
115 ABCC7 p.Trp1089*
X
ABCC7 p.Trp1089* 15371903:115:114
status: NEW
view ABCC7 p.Trp1089* details
The lack of detection in the carrier screening population of mutations identified among patients (e.g., 2307delA, W1089X) is not unexpected given the inherent variability in estimates of low-frequency mutations. Login to comment
116 ABCC7 p.Asp1270Asn
X
ABCC7 p.Asp1270Asn 15371903:116:168
status: NEW
view ABCC7 p.Asp1270Asn details
From direct comparison of patient and carrier screening populations tested for the same mutation panel, we also identified a Ͼ 100-fold increase in the number of D1270N chromosomes among African American carriers as compared with African American CF patients. Login to comment
117 ABCC7 p.Asp1270Asn
X
ABCC7 p.Asp1270Asn 15371903:117:0
status: NEW
view ABCC7 p.Asp1270Asn details
D1270N has been identified in individuals with cystic fibrosis24,33,35,36 as well as in men with congenital absence of the vas deferens.24,37 Similar discrepancies in mutation frequency between carrier and patient populations are now well known for the R117H15 and I148T38,39 sequence changes, each of which has a cis-acting modifier influencing phenotype (5T21 and 3199del6,40 respectively). Login to comment
118 ABCC7 p.Asp1270Asn
X
ABCC7 p.Asp1270Asn 15371903:118:100
status: NEW
view ABCC7 p.Asp1270Asn details
ABCC7 p.Asp1270Asn
X
ABCC7 p.Asp1270Asn 15371903:118:128
status: NEW
view ABCC7 p.Asp1270Asn details
ABCC7 p.Asp1270Asn
X
ABCC7 p.Asp1270Asn 15371903:118:361
status: NEW
view ABCC7 p.Asp1270Asn details
ABCC7 p.Asp1270Asn
X
ABCC7 p.Asp1270Asn 15371903:118:494
status: NEW
view ABCC7 p.Asp1270Asn details
ABCC7 p.Arg74Trp
X
ABCC7 p.Arg74Trp 15371903:118:37
status: NEW
view ABCC7 p.Arg74Trp details
ABCC7 p.Arg74Trp
X
ABCC7 p.Arg74Trp 15371903:118:135
status: NEW
view ABCC7 p.Arg74Trp details
ABCC7 p.Arg74Trp
X
ABCC7 p.Arg74Trp 15371903:118:420
status: NEW
view ABCC7 p.Arg74Trp details
There have been similar reports that R74W may be a potential modifier for the clinical phenotype of D1270N.29 The ⌬F508/ D1270N-R74W genotype has been reported in a girl with CF symptoms,41 in 2 CF patients, 3 CBAVD patients,24 and a 27-year-old man with CBAVD, elevated sweat chlorides, recurrent respiratory infection, and rhinitis.35 Our study of 192 D1270N-positive specimens was not suggestive of a role for R74W as a modifying allele, and a definitive explanation for the variable D1270N frequencies remains unknown. Login to comment
119 ABCC7 p.Ser549Asn
X
ABCC7 p.Ser549Asn 15371903:119:96
status: NEW
view ABCC7 p.Ser549Asn details
ABCC7 p.Arg1066Cys
X
ABCC7 p.Arg1066Cys 15371903:119:88
status: NEW
view ABCC7 p.Arg1066Cys details
In the Hispanic population, our findings support the inclusion, minimally, of 3876delA, R1066C, S549N, and 1949del84 in a mutation panel. Login to comment
120 ABCC7 p.Trp1089*
X
ABCC7 p.Trp1089* 15371903:120:72
status: NEW
view ABCC7 p.Trp1089* details
Although not yet identified among our carrier screening population, the W1089X mutation with a 2.2% frequency among CF patients would also be valuable. Login to comment
122 ABCC7 p.Ala559Thr
X
ABCC7 p.Ala559Thr 15371903:122:179
status: NEW
view ABCC7 p.Ala559Thr details
Similar recommendations have been made by other groups to add mutations that would increase detection in the Hispanic popula- tin.13,18,32 In the African American population, the A559T mutation was the 4th most common mutation among CF patient chromosomes (2.78%) and the third most frequent among CF carriers (6.38%) and as such would warrant inclusion, with 711ϩ5GϾA (0.93%), in any screening program serving an African American population. Login to comment
125 ABCC7 p.Asp1270Asn
X
ABCC7 p.Asp1270Asn 15371903:125:28
status: NEW
view ABCC7 p.Asp1270Asn details
Table 4 Indications for 192 D1270N-positive patient samples Indication No. of Specimens Carrier testing-no family history 153 Carrier testing-family history 9 Carrier testing-abnormal fetal ultrasound findings 5 Known affected-CF diagnosis 3 Infertility 5 Suspected diagnosis (CF or pancreatitis) 15 Indication not provided 2 With 14% of our carrier screening referrals being from Hispanic and African American individuals, and another 12% from individuals with ethnicities other than the ACMG/ACOG recommended Caucasian or Ashkenazi Jewish, it is evident that clinicians are offering or making CF carrier screening available to a diverse population, many of whom choose testing. Login to comment
128 ABCC7 p.Asp1270Asn
X
ABCC7 p.Asp1270Asn 15371903:128:102
status: NEW
view ABCC7 p.Asp1270Asn details
ABCC7 p.Arg74Trp
X
ABCC7 p.Arg74Trp 15371903:128:85
status: NEW
view ABCC7 p.Arg74Trp details
We appreciate the assistance of Michelle Blalock, of the University of Virginia, for R74W analysis of D1270N-positive specimens and Stephen Lake for support with statistical calculations. Login to comment